Filters
Other countries
Results: 1 to 7 of 7
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
FSHD (Facioscapulohumeral muscular dystrophy) TYPE 1 Revvity Omics Revvity United States | 1 | 1 |
|
Facioscapulohumeral muscular dystrophy type 1 (FSHD1) Molecular Diagnostics Platform_Biogipuzkoa Health Research Institute Biogipuzkoa Health Research Institute Spain | 1 | 1 |
|
Fulgent Genetics United States | 15 | 1 |
|
CeGaT GmbH Germany | 37 | 32 |
|
Fulgent Genetics United States | 1 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Facioscapulohumeral muscular dystrophy 1A Praxis fuer Humangenetik Wien Austria | 1 | 1 |
|
Results: 1 to 7 of 7
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.